Collegium Pharmaceutical Stock Forecast
NASDAQ: COLLHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Pre-market: 22.34 +1.04%
COLL analyst consensus
Consensus (8 analysts)
strong_buy
Avg. price target
$49.00+121.62%
- Strong buy 2
- Buy 5
- Hold 1
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
What analysts say
According to 8 Wall Street analysts covering Collegium Pharmaceutical (2026-10-08), 7 rate the stock a buy or strong buy, 1 rate it a hold and 0 rate it a sell or strong sell, for a consensus rating of "strong_buy". The average 12-month price target is $49.00, with a high estimate of $60.00 and a low estimate of $43.00. The average target implies upside of 121.6% from the current price of $22.11.
The spread between the highest and lowest targets is 39.5%, a relatively narrow range. Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for COLL.
Summary generated from market data by MetaCap's automated system. Methodology
Rating distribution
| Rating | Analysts | Share |
|---|---|---|
| Strong buy | 2 | 25% |
| Buy | 5 | 63% |
| Hold | 1 | 13% |
| Sell | 0 | 0% |
| Strong sell | 0 | 0% |
Ratings as of 2026-10-08.
Price target scenarios
| Target | Price | vs. current |
|---|---|---|
| Low target | $43.00 | +94.48% |
| Average target | $49.00 | +121.62% |
| High target | $60.00 | +171.37% |